Depressive symptoms and biomarkers of Alzheimer's disease in cognitively normal older adults

Journal of Alzheimer's Disease

Volumn 46, Issue 1, 2015, Pages 63-73

  Donovan, Nancy J ^a,b   Hsu, David C ^a,b   Dagley, Alexander S ^b   Schultz, Aaron P ^b   Amariglio, Rebecca E ^a,b   Mormino, Elizabeth C ^b   Okereke, Olivia I ^a,b   Rentz, Dorene M ^a,b   Johnson, Keith A ^a,b   Sperling, Reisa A ^a,b   Marshall, Gad A ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Alzheimer's disease; biomarkers; neurodegeneration; normal cognition; preclinical; subthreshold depressive symptoms

Indexed keywords

AMYLOID PROTEIN; BIOLOGICAL MARKER; FLUORODEOXYGLUCOSE F 18; 2-(4'-(METHYLAMINO)PHENYL)-6-HYDROXYBENZOTHIAZOLE; AMYLOID BETA PROTEIN; ANILINE DERIVATIVE; THIAZOLE DERIVATIVE;

AGE; AGED; ALZHEIMER DISEASE; ANHEDONIA; ANXIETY; APATHY; ARTICLE; BRAIN CORTEX; BRAIN METABOLISM; BRAIN SIZE; COGNITION; COHORT ANALYSIS; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DEPRESSION; DYSPHORIA; FEMALE; GENDER; GERIATRIC DEPRESSION SCALE; HIPPOCAMPUS; HUMAN; INTELLIGENCE; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MENTAL CONCENTRATION; NERVE DEGENERATION; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SYMPTOM; AGING; ANIMAL; COMPLICATION; DEMOGRAPHY; DIAGNOSTIC IMAGING; GERIATRIC ASSESSMENT; METABOLISM; PATHOLOGY; PSYCHOLOGICAL RATING SCALE; STATISTICAL MODEL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANILINE COMPOUNDS; ANIMALS; BIOMARKERS; DEPRESSION; FEMALE; FLUORODEOXYGLUCOSE F18; GERIATRIC ASSESSMENT; HIPPOCAMPUS; HUMANS; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; POSITRON-EMISSION TOMOGRAPHY; PRINCIPAL COMPONENT ANALYSIS; PSYCHIATRIC STATUS RATING SCALES; RESIDENCE CHARACTERISTICS; THIAZOLES;

EID: 84929353529     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-142940     Document Type: Article

References (65)

1. Donovan NJ, Amariglio RE, Zoller AS, Rudel RK, Gomez-Isla T, Blacker D, Hyman BT, Locascio JJ, Johnson KA, Sperling RA, Marshall GA, Rentz DM (2014) Subjective cognitive concerns and neuropsychiatric predictors of progression to the early clinical stages of Alzheimer disease. Am J Geriatr Psychiatry 22, 1642-1651.
2. Geda YE, Roberts RO, Mielke MM, Knopman DS, Chris-tianson TJ, Pankratz VS, Boeve BF, Sochor O, Tangalos EG, Petersen RC, Rocca WA (2014) Baseline neuropsychiatric symptoms and the risk of incident mild cognitive impairment: A population-based study. Am J Psychiatry 171, 572-581.
3. Steenland K, Karnes C, Seals R, Carnevale C, Hermida A, Levey A (2012) Late-life depression as a risk factor for mild cognitive impairment or Alzheimer's disease in 30 US Alzheimer's disease centers. J Alzheimers Dis 31, 265-275.
4. Barnes DE, Alexopoulos GS, Lopez OL, Williamson JD, Yaffe K (2006) Depressive symptoms, vascular disease, and mild cognitive impairment: Findings from the Cardiovascular Health Study. Arch Gen Psychiatry 63, 273-279.
5. Judd LL, Akiskal HS, Paulus MP (1997) The role and clinical significance of subsyndromal depressive symptoms (SSD) in unipolar major depressive disorder. J Affect Disord 45, 5-17; discussion 17-18.
6. Lyness JM, Kim J, Tang W, Tu X, Conwell Y, King DA, Caine ED (2007) The clinical significance of subsyndromal depression in older primary care patients. A J Geriatr Psychiatry 15, 214-223.
7. Dotson VM, Beason-Held L, Kraut MA, Resnick SM (2009) Longitudinal study of chronic depressive symptoms and regional cerebral blood flow in older men and women. Int J Geriatr Psychiatry 24, 809-819.
8. Lavretsky H, Kumar A (2002) Clinically significant nonmajor depression: Old concepts, new insights. Am J Geriatr Psychiatry 10, 239-255.
9. Lyness JM, Heo M, Datto CJ, Ten Have TR, Katz IR, Drayer R, Reynolds CF, 3rd, Alexopoulos GS, Bruce ML (2006) Outcomes of minor and subsyndromal depression among elderly patients in primary care settings. Ann Intern Med 144, 496-504.
10. Lyness JM, Chapman BP, McGriff J, Drayer R, Duberstein PR (2009) One-year outcomes of minor and subsyndromal depression in older primary care patients. Int Psychogeriatr 21, 60-68.
11. Beekman AT, Geerlings SW, Deeg DJ, Smit JH, Schoevers RS, de Beurs E, Braam AW, Penninx BW, van Tilburg W (2002) The natural history of late-life depression: A 6-year prospective study in the community. Arch Gen Psychiatry 59, 605-611.
12. Cui X, Lyness JM, Tang W, Tu X, Conwell Y (2008) Outcomes and predictors of late-life depression trajectories in older primary care patients. Am J Geriatr Psychiatry 16, 406-415.
13. Ludvigsson M, Milberg A, Marcusson J, Wressle E (2014) Normal aging or depression? A qualitative study on the differences between subsyndromal depression and depression in very old people. Gerontologist. doi: 10.1093/geront/gnt162
14. Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MW (1996) Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci U S A 93, 3908-3913.
15. Steffens DC, McQuoid DR, Payne ME, Potter GG (2011) Change in hippocampal volume on magnetic resonance imaging and cognitive decline among older depressed and nondepressed subjects in the neurocognitive outcomes of depression in the elderly study. Am J Geriatr Psychiatry 19, 4-12.
16. den Heijer T, Tiemeier H, Luijendijk HJ, van der Lijn F, Koudstaal PJ, Hofman A, Breteler MM (2011) A study of the bidirectional association between hippocampal volume on magnetic resonance imaging and depression in the elderly. Biol Psychiatry 70, 191-197.
17. O'Brien JT, Lloyd A, McKeith I, Gholkar A, Ferrier N (2004) A longitudinal study of hippocampal volume, cortisol levels, and cognition in older depressed subjects. Am J Psychiatry 161, 2081-2090.
18. Alexopoulos GS (2002) Frontostriatal and limbic dysfunction in late-life depression. Am J Geriatr Psychiatry 10, 687-695.
19. Sheline YI, Pieper CF, Barch DM, Welsh-Bohmer K, McKinstry RC, MacFall JR, D'Angelo G, Garcia KS, Gersing K, Wilkins C, Taylor W, Steffens DC, Krishnan RR, Doraiswamy PM (2010) Support for the vascular depression hypothesis in late-life depression: Results of a 2-site, prospective, antidepressant treatment trial. Arch Gen Psychiatry 67, 277-285.
20. Wu D, Yuan Y, Bai F, You J, Li L, Zhang Z (2013) Abnormal functional connectivity of the default mode network in remitted late-onset depression. J Affect Disord 147, 277-287.
21. Royall DR, Palmer RF (2013) Alzheimer's disease pathology does not mediate the association between depressive symptoms and subsequent cognitive decline. Alzheimers Dement 9, 318-325.
22. Lee JY, Park S, Mackin S, Ewers M, Chui H, Jagust W, Insel PS, Weiner MW (2014) Differences in prefrontal, limbic, and white matter lesion volumes according to cognitive status in elderly patients with first-onset subsyndromal depression. PLoS One 9, e87747.
23. Pomara N, Bruno D, Sarreal AS, Hernando RT, Nierenberg J, Petkova E, Sidtis JJ, Wisniewski TM, Mehta PD, Pratico D, Zetterberg H, Blennow K (2012) Lower CSF amyloid beta peptides and higher F2-isoprostanes in cognitively intact elderly individuals with major depressive disorder. Am J Psychiatry 169, 523-530.
24. Gerritsen L, Comijs HC, van der Graaf Y, Knoops AJ, Penninx BW, Geerlings MI (2011) Depression, hypothalamic pituitary adrenal axis, and hippocampal and entorhinal cortex volumes-the SMART Medea study. Biol Psychiatry 70, 373-380.
25. Ballmaier M, Narr KL, Toga AW, Elderkin-Thompson V, Thompson PM, Hamilton L, Haroon E, Pham D, Heinz A, Kumar A (2008) Hippocampal morphology and distinguishing late-onset from early-onset elderly depression. Am J Psychiatry 165, 229-237.
26. Apostolova LG, Mosconi L, Thompson PM, Green AE, Hwang KS, Ramirez A, Mistur R, Tsui WH, de Leon MJ (2010) Subregional hippocampal atrophy predicts Alzheimer's dementia in the cognitively normal. Neurobiol Aging 31, 1077-1088.
27. Wilson RS, Capuano AW, Boyle PA, Hoganson GM, Hizel LP, Shah RC, Nag S, Schneider JA, Arnold SE, Bennett DA (2014) Clinical-pathologic study of depressive symptoms and cognitive decline in old age. Neurology 83, 702-709.
28. Landau SM, Harvey D, Madison CM, Koeppe RA, Reiman EM, Foster NL, Weiner MW, Jagust WJ, Alzheimer's Disease Neuroimaging I (2011) Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol Aging 32, 1207-1218.
29. Jack CR Jr., Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, Shaw LM, Vemuri P, Wiste HJ, Weigand SD, Lesnick TG, Pankratz VS, Donohue MC, Trojanowski JQ (2013) Tracking pathophysiological processes in Alzheimer's disease: An updated hypothetical model of dynamic biomark-ers. Lancet Neurol 12, 207-216.
30. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr., Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH (2011) Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 280-292.
31. Morris JC (1993) The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology 43, 2412-2414.
32. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198.
33. Weschler D (1987) WMS-R Weschler Memory Scale Revised Manual, Ths Psychological Corporation, Harcourt Brace Jovanovich, Inc, New York.
34. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, Leirer VO (1982) Development and validation of a geriatric depression screening scale: A preliminary report. J Psychiatr Res 17, 37-49.
35. Paolo AM, Ryan JJ (1992) Generalizability of two methods of estimating premorbid intelligence in the elderly. Arch Clin Neuropsychol 7, 135-143.
36. Becker JA, Hedden T, Carmasin J, Maye J, Rentz DM, Putcha D, Fischl B, Greve DN, Marshall GA, Salloway S, Marks D, Buckner RL, Sperling RA, Johnson KA (2011) Amyloid-beta associated cortical thinning in clinically normal elderly. Ann Neurol 69, 1032-1042.
37. Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergstrom M, Savitcheva I, Huang GF, Estrada S, Ausen B, Debnath ML, Barletta J, Price JC, Sandell J, Lopresti BJ, Wall A, Koivisto P, Antoni G, Mathis CA, Langstrom B (2004) Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 55, 306-319.
38. Hedden T, Mormino EC, Amariglio RE, Younger AP, Schultz AP, Becker JA, Buckner RL, Johnson KA, Sperling RA, Rentz DM (2012) Cognitive profile of amyloid burden and white matter hyperintensities in cognitively normal older adults. J Neurosci 32, 16233-16242.
39. Johnson KA, Gregas M, Becker JA, Kinnecom C, Salat DH, Moran EK, Smith EE, Rosand J, Rentz DM, Klunk WE, Mathis CA, Price JC, Dekosky ST, Fischman AJ, Greenberg SM (2007) Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Ann Neurol 62, 229-234.
40. Mormino EC, Betensky RA, Hedden T, Schultz AP, Ward A, Huijbers W, Rentz DM, Johnson KA, Sperling RA, Alzheimer's Disease Neuroimaging I, Australian Imaging B, Lifestyle Flagship Study of A, Harvard Aging Brain S (2014) Amyloid and APOE epsilon4 interact to influence short-term declinein preclinical Alzheimer disease. Neurology82, 1760-1767.
41. Gudmundsson P, Skoog I, Waern M, Blennow K, Palsson S, Rosengren L, Gustafson D (2007) The relationship between cerebrospinal fluid biomarkers and depression in elderly women. Am J Geriatr Psychiatry 15, 832-838.
42. Madsen K, Hasselbalch BJ, Frederiksen KS, Haahr ME, Gade A, Law I, Price JC, Knudsen GM, Kessing LV, Hasselbalch SG (2012) Lack of association between prior depressive episodes and cerebral [11C] PiB binding. Neurobiol Aging 33, 2334-2342.
43. Butters MA, Klunk WE, Mathis CA, Price JC, Ziolko SK, Hoge JA, Tsopelas ND, Lopresti BJ, Reynolds CF, 3rd, DeKosky ST, Meltzer CC (2008) Imaging Alzheimer pathology in late-life depression with PET and Pittsburgh Compound-B. Alzheimer Dis Assoc Disord 22, 261-268.
44. Diniz BS, Sibille E, Ding Y, Tseng G, Aizenstein HJ, Lotrich F, Becker JT, Lopez OL, Lotze MT, Klunk WE, Reynolds CF, Butters MA (2014) Plasma biosignature and brain pathology related to persistent cognitive impairment in late-life depression. Mol Psychiatry doi: 10.1038/mp.2014.76
45. Jack CR Jr, Wiste HJ, Weigand SD, Knopman DS, Lowe V, Vemuri P, Mielke MM, Jones DT, Senjem ML, Gunter JL, Gregg BE, Pankratz VS, Petersen RC (2013) Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity. Neurology 81, 1732-1740.
46. Knopman DS, Jack CR Jr., Wiste HJ, Weigand SD, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Roberts RO, Boeve BF, Petersen RC (2013) Brain injury biomarkers are not dependent on beta-amyloid in normal elderly. Ann Neurol 73, 472-480.
47. Sheline YI (1996) Hippocampal atrophy in major depression: A result of depression-induced neurotoxicity?Mol Psychiatry 1, 298-299.
48. Sheline YI, Sanghavi M, Mintun MA, Gado MH (1999) Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci 19, 5034-5043.
49. O'Brien JT, Lloyd A, McKeith I, Gholkar A, Ferrier N (2004) A longitudinal study of hippocampal volume, cortisol levels, and cognition in older depressed subjects. Am J Psychiatry 161, 2081-2090.
50. Schonheit B, Zarski R, Ohm TG (2004) Spatial and temporal relationships between plaques and tangles in Alzheimer-pathology. Neurobiol Aging 25, 697-711.
51. Jack CR Jr., Shiung MM, Gunter JL, O'Brien PC, Weigand SD, Knopman DS, Boeve BF, Ivnik RJ, Smith GE, Cha RH, Tangalos EG, Petersen RC (2004) Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology 62, 591-600.
52. Jack CR Jr., Wiste HJ, Knopman DS, Vemuri P, Mielke MM, Weigand SD, Senjem ML, Gunter JL, Lowe V, Gregg BE, Pankratz VS, Petersen RC (2014) Ratesofbeta-amyloid accumulation are independent of hippocampal neurodegeneration. Neurology 82, 1605-1612.
53. Fjell AM, McEvoy L, Holland D, Dale AM, Walhovd KB, Alzheimer's Disease Neuroimaging I (2013) Brain changes in older adults at very low risk for Alzheimer's disease. J Neurosci 33, 8237-8242.
54. McDonald CR Jr, McEvoy LK, Gharapetian L, Fennema-Notestine C, Hagler DJ, Holland D, Koyama A, Brewer JB, Dale AM, Alzheimer's Disease Neuroimaging I (2009) Regional rates of neocortical atrophy from normal aging to early Alzheimer disease. Neurology 73, 457-465.
55. Fjell AM, McEvoy L, Holland D, Dale AM, Walhovd KB, Alzheimer's Disease Neuroimaging, Imaging (2014) What is normal in normal aging? Effects of aging, amyloid and Alzheimer's disease on the cerebral cortex and the hippocampus. Prog Neurobiol 117, 20-40.
56. Kumar A, Ajilore O, Zhang A, Pham D, Elderkin-Thompson V (2014) Cortical thinning in patients with late-life minor depression. Am J Geriatr Psychiatry 22, 459-464.
57. Dotson VM, Davatzikos C, Kraut MA, Resnick SM (2009) Depressive symptoms and brain volumes in older adults: A longitudinal magnetic resonance imaging study. J Psychiatry Neurosci 34, 367-375.
58. Covinsky KE, Cenzer IS, Yaffe K, O'Brien S, Blazer DG (2014) Dysphoria and anhedonia as risk factors for disability or death in older persons: Implications for the assessment of geriatric depression. Am J Geriatr Psychiatry 22, 606-613.
59. Wadsworth LP, Lorius N, Donovan NJ, Locascio JJ, Rentz DM, Johnson KA, Sperling RA, Marshall GA (2012) Neu-ropsychiatric symptoms and global functional impairment along the Alzheimer's continuum. Dement Geriatr Cogn Dis-ord 34, 96-111.
60. Palmer K, Di Iulio F, Varsi AE, Gianni W, Sancesario G, Caltagirone C, Spalletta G (2010) Neuropsychiatric predictors of progression from amnestic-mild cognitive impairment to Alzheimer's disease: The role of depression and apathy. J Alzheimers Dis 20, 175-183.
61. Delrieu J, Desmidt T, Camus V, Sourdet S, Boutoleau-Bretonniere C, Mullin E, Vellas B, Payoux P, Lebouvier T, Alzheimer's Disease Neuroimaging Imaging (2014) Apathy as a feature of prodromal Alzheimer's disease: An FDG-PET ADNI study. Int J Geriatr Psychiatry. doi: 10.1002/gps.4161
62. Marshall GA, Donovan NJ, Lorius N, Gidicsin CM, Maye J, Pepin LC, Becker JA, Amariglio RE, Rentz DM, Sperling RA, Johnson KA (2013) Apathy is associated with increased amyloid burden in mild cognitive impairment. J Neuropsychiatry Clin Neurosci 25, 302-307.
63. Kim G, DeCoster J, Huang CH, Bryant AN (2013) A meta-analysis of the factor structure of the Geriatric Depression Scale (GDS): The effects of language. Int Psychogeriatr 25, 71-81.
64. Adams KB, Matto HC, Sanders S (2004) Confirmatory factor analysis of the geriatric depression scale. Gerontologist 44, 818-826.
65. Sheline YI, West T, Yarasheski K, Swarm R, Jasielec MS, Fisher JR, Ficker WD, Yan P, Xiong C, Frederiksen C, Grzelak MV, Chott R, Bateman RJ, Morris JC, Mintun MA, Lee JM, Cirrito JR (2014) Anantidepressant decreases CSF Abeta production in healthy individuals and in transgenic AD mice. Sci Transl Med 6, 236re234.